125 related articles for article (PubMed ID: 1683649)
1. Decrease in soluble CD8 antigen levels in splenectomized patients as an index for reduced suppressor/cytotoxic cell activity.
Weiss C; Wulf G; Ho AD; Hunstein W
Immunol Lett; 1991 Sep; 30(1):113-8. PubMed ID: 1683649
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of soluble CD8 and CD4 in patients with infectious mononucleosis.
Yoneyama A; Nakahara K; Higashihara M; Kurokawa K
Br J Haematol; 1995 Jan; 89(1):47-54. PubMed ID: 7833276
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte subpopulations and concentrations of soluble CD8 and CD4 antigen after anaerobic training.
Weiss C; Kinscherf R; Roth S; Friedmann B; Fischbach T; Reus J; Dröge W; Bärtsch P
Int J Sports Med; 1995 Feb; 16(2):117-21. PubMed ID: 7751074
[TBL] [Abstract][Full Text] [Related]
4. Changes in soluble CD4 and CD8 proteins in healthy pregnant and postpartum women.
Watanabe M; Iwatani Y; Hidaka Y; Mitsuda N; Amino N
Am J Reprod Immunol; 1996 Oct; 36(4):220-7. PubMed ID: 8911630
[TBL] [Abstract][Full Text] [Related]
5. Decrease in CD8+ lymphocytes in atopic dermatitis is associated with a preferential loss of cytotoxic effector cells rather than suppressor inducer cells.
McCoy JP; Hanley-Yanez K; Tharp MD
Ann N Y Acad Sci; 1993 Mar; 677():422-4. PubMed ID: 8494231
[No Abstract] [Full Text] [Related]
6. Changes in lymphocyte subpopulations in peripheral blood of splenectomized patients.
Brodsky E; Steiner Z; Manor Y; Schneider M; Druker I; Klajman A
Isr J Med Sci; 1988 Dec; 24(12):702-5. PubMed ID: 2976061
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte subsets and specific T-cell immune response in thalassemia.
Pattanapanyasat K; Thepthai C; Lamchiagdhase P; Lerdwana S; Tachavanich K; Thanomsuk P; Wanachiwanawin W; Fucharoen S; Darden JM
Cytometry; 2000 Feb; 42(1):11-7. PubMed ID: 10679738
[TBL] [Abstract][Full Text] [Related]
8. Increased serum CD8 soluble antigen level is associated with blood lymphocyte abnormalities and other established indicators of a poor prognosis in adult Hodgkin's disease.
Grimfors G; Andersson B; Tullgren O; Giscombe R; Holm G; Johansson B; Björkholm M
Br J Haematol; 1992 Feb; 80(2):166-71. PubMed ID: 1550771
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of soluble CD8 antigen and interleukin-2 receptor antigen in patients with hairy cell leukemia, relationship with splenectomy and with clinical response to therapy.
Ho AD; Grossmann M; Knauf W; Martin H; Trümper L; Zwingers T; Sonnen R; Pralle H; Hunstein W
Leukemia; 1989 Oct; 3(10):718-23. PubMed ID: 2506398
[TBL] [Abstract][Full Text] [Related]
10. [Lymphocyte populations and subpopulations in peripheral blood of pregnant women with pre-eclampsia].
Dimitrakova-Dzhambazova E; Milchev N; Pavlov P; Dimitrakov D
Akush Ginekol (Sofiia); 2005; 44(1):40-4. PubMed ID: 15853011
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis.
Aguilar-Santelises M; Loftenius A; Ljungh C; Svenson SB; Andersson B; Mellstedt H; Jondal M
Leuk Res; 1992; 16(6-7):607-13. PubMed ID: 1386130
[TBL] [Abstract][Full Text] [Related]
12. CD8+ suppressor cells inhibit staphylococcal protein A-induced gamma interferon production by CD4+ lymphocytes.
Kasparian SS; Menezes J
Immunol Lett; 1991 Jan; 27(1):31-7. PubMed ID: 1673445
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of serum levels of soluble CD4, CD8 and beta 2-microglobulin in visceral human leishmaniasis.
Vitale G; Mocciaro C; Malta R; Gambino G; Spinelli A; Giordano C; Stassi G; Arcoleo F; Milano S; Cillari E
Clin Exp Immunol; 1994 Aug; 97(2):280-3. PubMed ID: 8050177
[TBL] [Abstract][Full Text] [Related]
14. Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-inducer lymphocytes and CD8+ suppressor/cytotoxic lymphocytes.
Baadsgaard O; Fox DA; Cooper KD
J Immunol; 1988 Mar; 140(6):1738-44. PubMed ID: 2964481
[TBL] [Abstract][Full Text] [Related]
15. Small lymphocytic non-Hodgkin's lymphoma of suppressor/cytotoxic T-cell phenotype [CD4(-), CD8(+)].
Dorfman DM; Longtine JA; Weinberg DS; Pinkus GS
Hum Pathol; 1993 Nov; 24(11):1253-6. PubMed ID: 8244326
[TBL] [Abstract][Full Text] [Related]
16. Analysis of T helper and suppressor lymphocyte subsets in relation to the clinical stage of solid neoplasms.
Tancini G; Barni S; Rescaldani R; Fiorelli G; Vivani S; Lissoni P
Oncology; 1990; 47(5):381-4. PubMed ID: 2145536
[TBL] [Abstract][Full Text] [Related]
17. Serum soluble CD4 and CD8 levels in Kawasaki disease.
Furukawa S; Matsubara T; Tsuji K; Motohashi T; Okumura K; Yabuta K
Clin Exp Immunol; 1991 Oct; 86(1):134-9. PubMed ID: 1914226
[TBL] [Abstract][Full Text] [Related]
18. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.
Spronk PE; ter Borg EJ; Huitema MG; Limburg PC; Kallenberg CG
Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD4 and CD8 in the peripheral blood of patients with multiple sclerosis and HTLV-1-associated myelopathy.
Tsukada N; Matsuda M; Miyagi K; Yanagisawa N
J Neuroimmunol; 1991 Dec; 35(1-3):285-93. PubMed ID: 1955570
[TBL] [Abstract][Full Text] [Related]
20. Fetal T-lymphocyte subpopulations in normal pregnancies.
Thilaganathan B; Mansur CA; Morgan G; Nicolaides KH
Fetal Diagn Ther; 1992; 7(2):53-61. PubMed ID: 1386986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
